Pharmaceuticals India News
  • Home
  • Brands
    • Alkem
    • Apollo Hospital
    • Aurobindo Pharma
    • Biocon
    • Cipla
    • Divi’s Laboratories
    • Dr Reddy’s
    • Fortis
    • Glenmark
    • Lupin
    • Mankind Pharma
    • Natco
    • Pfizer
    • Piramal Pharma
    • Sun Pharma
    • Torrent Pharma
    • Zydus
Select Page

Mankind Pharma clears hurdle as CDSCO panel approves bioequivalence study for Resmetirom Tablets.

by Team Small News | Mar 23, 2025 | Mankind, Pharma

Mankind Pharma, a leading pharmaceutical company in India, has reportedly received approval from the Central Drugs Standard Control Organization (CDSCO) panel for conducting a bioequivalence study of its Resmetirom Tablets. This development is significant for the...

Eli Lilly expands its global footprint by introducing Mounjaro, a groundbreaking weight management medication, to the Indian market.

by Team Small News | Mar 22, 2025 | Biocon, Cipla, Lupin, Mankind, Natco, Pharma

Eli Lilly & Co. has launched its anti-obesity drug Mounjaro in India, making it the country’s first treatment of its kind. The drug, which is used to treat obesity and type-2 diabetes, works by activating hormones that help reduce the amount of sugar in the...

India sees a significant decrease in the price of a commonly used diabetes medication following the introduction of generic alternatives.

by Team Small News | Mar 13, 2025 | Alkem, Glenmark, Mankind, Pharma

The price of the diabetes drug empagliflozin, also known as Jardiance, has been significantly reduced by almost one-tenth in India. The drug, developed by German pharma giant Boehringer Ingelheim, is used to control blood sugar levels in patients with type 2 diabetes....
This popular diabetes medication is set to get a significant price cut, dropping from Rs 60 to just Rs 9 per unit.

This popular diabetes medication is set to get a significant price cut, dropping from Rs 60 to just Rs 9 per unit.

by Team Small News | Mar 11, 2025 | Alkem, Lupin, Mankind, Pharma, Torrent Pharma

The cost of Empagliflozin, a crucial drug for managing diabetes and its associated conditions, is set to drop significantly in India. The price of the medicine, which was previously around Rs 60 per tablet, will be reduced to just Rs 9 per tablet, making it more...
Next Entries »

_________

Pharna Brands

  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma
  • Torrent Pharma
  • Zydus
  • Alkem
  • Apollo Hospital
  • Aurobindo Pharma
  • Biocon
  • Cipla
  • Torrent Pharma
  • Divi’s Laboratories
  • Dr Reddy’s
  • Fortis
  • Glenmark
  • Lupin
  • Zydus
  • Mankind Pharma
  • Natco
  • Pfizer
  • Piramal Pharma
  • Sun Pharma

    Designed by Elegant Themes | Powered by WordPress